2021
- 2021. 08.Certificate of INNOBIZ
- 2021. 03.2021 Korea Inovation Award in Technology Innovation
2020
- 2020. 11.Series C funding ($31M)
- 2020. 04.Split of stock
- 2020. 03.Increase of capital stock without consideration (bonus issue)
2019
- 2019. 12.Additional Series B’ funding
- 2019. 09.Registration of OHPASTM trademark
- 2020. 02.Recipient of KDDF funded by MSIT, MOTIE, and MOHW
2018
- 2018. 07.Relocation to Current Headquarters
- 2018. 03.Series B funding
2017
- 2017. 08.Initiation of B7-H3 ADC program
- 2017. 07.Patent application on OHPASTM Linker
2016
- 2016. 09.Series A' funding
- 2016. 01.Series A funding
2015
- 2015. 06.New R&D center in Daejeon
- 2015. 04.Seed funding from angel investors
- 2015. 04.Certificate of venture company
- 2015. 04.Founding of IntoCell